|
UCSF Comprehensive Cancer Center Professionals Win Society of Clinical Research Associates (SoCRA) Poster Contest
Fremont, CA - Velos, Inc., provider of the market-leading Velos eResearch clinical
trial management system, is pleased to congratulate professionals from the UCSF Comprehensive Cancer
Center for winning top honors in the poster contest at the Society of Clinical Research Associates
(SoCRA) 15th Annual Conference in Chicago, IL, September 22-24. The poster session, entitled
“Electronic Data Capture in Clinical Trials Management – Challenges in Deployment at an NCI
Comprehensive Cancer Center”, was authored by Beverly Fein, RN, De’Anna Castro, and Karen Kimura.
The poster details aspects of their successful implementation of a clinical trial management system
(CTMS), including:
- The key objectives for installing a CTMS. These included: 1) eliminate duplicate work, 2) reduce
paper, and 3) resolve other information ailments common to many Comprehensive Cancer
Centers.
- The implementation and buy-in process with a particular focus on the Protocol Review
Committee, Pharmacy Rollout, and NCI Data Reports.
- Conclusions and recommendations based on their achievement.
The authors also acknowledge the UCSF oncology staff in Clinical Research Support Services within the
UCSF Comprehensive Cancer Center, and their pharmacists, Protocol Review Committee investigators,
statisticians, and clinical research coordinators.
The full text of the poster can be found here.
-----------------------------------
About Velos
Velos Inc., www.velos.com, is a leading provider of next-generation healthcare software. Velos develops, markets, and supports an integrated suite of clinical, administrative, and financial products. Velos eResearch (www.veloseresearch.com), the company’s flagship clinical trial management product line, has been chosen by leading medical centers in academic medicine and research. Velos’ specialty medical product line supports the information needs of healthcare providers in cardiology, cardiovascular surgery, dialysis, and transplantation. Velos is privately held with headquarters in Fremont.
This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.
|
